TrialHaematologica2018

Unsatisfactory efficacy in randomized study of reduced-dose CPX-351 for medically less fit adults with newly diagnosed acute myeloid leukemia or other high-grade myeloid neoplasm.

Roland B Walter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.